Keyphrases
Revascularization
83%
Severe Ischemia
79%
Venovenous Bypass
75%
Treatment First
75%
Endovascular Treatment
75%
Chronic Limb-threatening Ischemia
62%
Angioplasty
54%
Infrapopliteal
52%
Phase II Trial
50%
Limb Perfusion
31%
Infrainguinal Revascularization
29%
Timing of Death
25%
Cause of Death
25%
Clinical Analysis
25%
Bare Metal
25%
Infrapopliteal Disease
25%
Balloon
25%
Treatment Group
18%
Amputation-free Survival
17%
Plain Balloon Angioplasty
15%
Confidence Interval
15%
Femoropopliteal
15%
Major Amputation
13%
Endovascular
12%
Adjusted Hazard Ratio
11%
Drug-coated Balloon Angioplasty
11%
Drug-eluting
11%
Infrapopliteal Revascularization
10%
Serious Adverse Events
9%
Excess Mortality
8%
Percutaneous Coronary Intervention
8%
Coronary Artery Bypass Grafting
8%
Delphi Panel
8%
Noncardiac
8%
Tissue Loss
6%
Surgery Department
6%
Vascular Surgery
6%
Ischemic Pain
6%
Sweden
6%
Peripheral Arterial Disease
6%
Cost-utility Analysis
6%
National Institute for Health Research
6%
Healthcare Research
6%
Medicine and Dentistry
Ischemia
100%
Revascularization
91%
Vein Bypass
75%
Limb
65%
Angioplasty
54%
Amputation
35%
Limb Perfusion
31%
Percutaneous Transluminal Angioplasty
27%
Diseases
27%
Arm
25%
Randomized Controlled Trial
25%
Bare Metal Stenting
25%
Hazard Ratio
22%
Treatment Group
20%
Stenting
11%
Adverse Event
10%
Health Care Cost
9%
Myocardial Infarction
8%
Percutaneous Coronary Intervention
8%
Coronary Artery Bypass Graft
8%
Vascular Surgery
6%
Unit Surgery
6%
Arteriosclerosis Obliterans
6%
Cost-Effectiveness Analysis
6%
Hospital Cost
6%
